Centocor - PDFSEARCH.IO - Document Search Engine

Centocor
Results: 172

#	Item
21	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab) Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Medicine Psoriasis Centocor Health Efalizumab Ustekinumab European Medicines Agency Adalimumab Natalizumab Immunosuppressants Monoclonal antibodies Pharmacology
22	July 2014 PBAC OUTCOMES - Deferrals Drug Name, form(s), strength(s), Sponsor, Type of submission Drug Type and Use Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Pharmacology Medicine Healthcare in Australia Pharmaceutical Benefits Scheme Pharmaceuticals policy Health Ruxolitinib Infliximab Ustekinumab Immunosuppressants Centocor Monoclonal antibodies
23	Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD, Duke Clinical Research Instit Add to Reading List Source URL: www.mesoblast.com Language: English* - Date: 2013-12-30 22:55:11 Infliximab Schering-Plough Pharmacology Medicine Monoclonal antibodies Centocor Immunosuppressants
24	aa-sEP-2an 16:18 DEPT OF HERLTH 2u,69 Add to Reading List Source URL: www.hkam.org.hk Language: English - Date: 2014-02-19 00:52:27 Monoclonal antibodies Immunology Centocor Arthritis Infliximab Adalimumab Etanercept Rheumatoid arthritis Pharmaceutical drug Pharmacology Immunosuppressants Medicine
25	Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Afternoon Session FDA Introductory Remarks Kendall A. Marcus, MD Add to Reading List Source URL: www.fda.gov Language: English Monoclonal antibodies Immunology Centocor Autoimmune diseases Ustekinumab Psoriasis Infliximab Adalimumab Etanercept Immunosuppressants Medicine Pharmacology
26	Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD, Duke Clinical Research Instit Add to Reading List Source URL: mesoblast.com Language: English* - Date: 2013-12-30 22:55:11 Infliximab Schering-Plough Pharmacology Medicine Monoclonal antibodies Centocor Immunosuppressants
27	Severe chronic plaque psoriasis Initial PBS authority application and supporting information Who needs to complete this form Add to Reading List Source URL: www.humanservices.gov.au Language: English - Date: 2014-09-09 22:04:36 Medicine Centocor Psoriasis Autoimmune diseases Ustekinumab Infliximab Adalimumab Etanercept Immunosuppressants Monoclonal antibodies Pharmacology
28	Ankylosing spondylitis Continuing PBS authority application Supporting information Purpose of this form Authority prescription form Add to Reading List Source URL: www.humanservices.gov.au Language: English - Date: 2015-02-11 18:54:25 Health Monoclonal antibodies Centocor Rheumatology Autoimmune diseases Infliximab Ankylosing spondylitis Etanercept Adalimumab Medicine Pharmacology Immunosuppressants
29	WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following Add to Reading List Source URL: www.watag.org.au Language: English - Date: 2012-12-16 22:40:24 Gastroenterology Immunosuppressants Monoclonal antibodies Centocor Infliximab Management of ulcerative colitis Ulcerative colitis TNF inhibitor Colitis Medicine Health Autoimmune diseases
30	Therapeutic Area Central Nervous System JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. and E.U. DEVELOPMENT OR REGISTRATION As of January 25, 2011* Add to Reading List Source URL: files.shareholder.com Language: English Dow Jones Industrial Average New Brunswick New Jersey Interventional cardiology Telaprevir Mentor Cordis Rivaroxaban Millennium Pharmaceuticals Dapoxetine Medicine Johnson & Johnson Centocor

UPDATE